First US biotech lists on Hong Kong Stock Exchange
Axiom Biosciences has announced plans to pursue an initial public offering on the Main Board of The Stock Exchange of Hong Kong (HKEX). The company says it believes the proposed listing would position it as the first US biotechnology company to pursue a primary listing in Hong… Read More